Duloxetine for the Treatment of Generalized Anxiety Disorder

Clinical trial NCT00803361 · COMPLETED

Trial details

NCT number: NCT00803361
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2008-12-01
Primary completion: 2010-01-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.